AusPAR: Rituximab

Australian Public Assessment Report

AusPAR

AusPAR: Rituximab [PDF, 806.77 KB]

AusPAR: Rituximab [Word, 1.27 MB]

Attachment: Product Information: Rutiximab [PDF, 601.02 KB]

Attachment: Product Information: Rutiximab [Word, 437.5 KB]

Attachment: Extract from Clinical Evaluation Report: Rutiximab [PDF, 1.25 MB]

Attachment: Extract from Clinical Evaluation Report: Rutiximab [Word, 2 MB]

Device/Product Name

MabThera

Active ingredients

Rituximab

AusPAR Date

13 August 2013

Published

21 October 2013

Submission Number

PM-2012-00331-3-3

Submission Type

Extension of indications

Decision

Approved